Alcon Inc stock is traded at $74.94, with a volume of 3,123,892. It is down -2.10% in the last 24 hours and up +18.59% over the past month. Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Previous Close:
$76.55
Open:
$74.24
24h Volume:
3,123,892
Relative Volume:
1.54
Market Cap:
$36.23B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
45.21
EPS:
$1.66
Net Cash Flow:
$1.59B
1W Performance:
+4.88%
1M Performance:
+18.59%
6M Performance:
+14.57%
1Y Performance:
+0.90%
1-Day Range:
$74.01$75.23
1-Week Range:
$72.03$77.85
52-Week Range:
$61.84$87.64
Alcon Inc Stock (ALC) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS